等待開盤 09-24 09:30:00 美东时间
-1.270
-0.86%
今日重点评级关注:HC Wainwright & Co.:维持Gossamer Bio"买入"评级,目标价从2美元升至90美元;巴克莱:维持Ultragenyx Pharmaceutical"超配"评级,目标价从32美元升至35美元
09-22 16:25
Barclays analyst Guy Hardwick maintains CDW (NASDAQ:CDW) with a Equal-Weight and lowers the price target from $150 to $148.
09-21 20:40
CDW ( ($CDW) ) has issued an update. On September 14, 2026, CDW LLC and CDW Fin...
09-16 05:21
今日重点评级关注:Chardan Capital:维持Hyperion DeFi"买入"评级,目标价从7.3美元升至8.45美元;摩根大通:维持Vera Therapeutics"超配"评级,目标价从76美元升至83美元
09-09 15:36
Barclays analyst Guy Hardwick maintains CDW (NASDAQ:CDW) with a Equal-Weight and raises the price target from $123 to $150.
09-08 21:40
• CDW的股价动能受到主要机构持仓披露的推动。 • 强劲的第二季度财务业绩超出了华尔街对利润和销售额的预期。 • 该公司凭224.2亿美元的年营收领跑行业。
08-25 19:16
• CDW's stock momentum was driven by major institutional position disclosures. • Strong second-quarter financial results surpassed Wall Street profit and sales expectations. • The company leads its industry with $22.42B in annual revenue.
08-25 19:15
今日重点评级关注:康托·菲茨杰拉德:维持EyePoint"超配"评级,目标价从47美元升至55美元;伯恩斯坦:维持Figure Technology"跑赢大市"评级,目标价从67美元升至70美元
08-07 13:41
Morgan Stanley analyst Erik Woodring maintains CDW (NASDAQ:CDW) with a Overweight and raises the price target from $170 to $171.
08-07 01:29
华盛资讯8月6日讯,CDW Corp公布2026财年Q2业绩,公司Q2营收65.72亿美元,同比增长10.0%,归母净利润2.74亿美元,同比增长1.2%。
08-06 04:25